nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—Fenbufen—Balsalazide—Crohn's disease	0.269	1	CrCrCtD
Ketorolac—PTGS2—Crohn's disease	0.235	1	CbGaD
Ketorolac—PTGS2—Balsalazide—Crohn's disease	0.101	0.241	CbGbCtD
Ketorolac—PTGS1—Balsalazide—Crohn's disease	0.0849	0.204	CbGbCtD
Ketorolac—PTGS2—Mesalazine—Crohn's disease	0.0804	0.193	CbGbCtD
Ketorolac—PTGS1—Mesalazine—Crohn's disease	0.0679	0.163	CbGbCtD
Ketorolac—PTGS2—Sulfasalazine—Crohn's disease	0.0449	0.108	CbGbCtD
Ketorolac—PTGS1—Sulfasalazine—Crohn's disease	0.0379	0.0911	CbGbCtD
Ketorolac—Tolmetin—CXCL8—Crohn's disease	0.000616	0.225	CrCbGaD
Ketorolac—Tolmetin—MPO—Crohn's disease	0.000479	0.175	CrCbGaD
Ketorolac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000428	0.137	CbGpPWpGaD
Ketorolac—Ketoprofen—CXCL8—Crohn's disease	0.0003	0.11	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—Crohn's disease	0.000227	0.0829	CrCbGaD
Ketorolac—Nepafenac—PTGS2—Crohn's disease	0.000216	0.0788	CrCbGaD
Ketorolac—Fenbufen—PTGS2—Crohn's disease	0.000207	0.0754	CrCbGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000195	0.0628	CbGpPWpGaD
Ketorolac—Oedema—Mercaptopurine—Crohn's disease	0.000195	0.00262	CcSEcCtD
Ketorolac—Breast disorder—Mesalazine—Crohn's disease	0.000194	0.00262	CcSEcCtD
Ketorolac—Pancytopenia—Azathioprine—Crohn's disease	0.000194	0.00261	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000194	0.00261	CcSEcCtD
Ketorolac—Nasopharyngitis—Mesalazine—Crohn's disease	0.000192	0.00259	CcSEcCtD
Ketorolac—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000191	0.00257	CcSEcCtD
Ketorolac—Gastritis—Mesalazine—Crohn's disease	0.00019	0.00256	CcSEcCtD
Ketorolac—Skin disorder—Mercaptopurine—Crohn's disease	0.000189	0.00255	CcSEcCtD
Ketorolac—Abdominal distension—Mesalazine—Crohn's disease	0.000187	0.00252	CcSEcCtD
Ketorolac—Asthma—Mesalazine—Crohn's disease	0.000186	0.0025	CcSEcCtD
Ketorolac—Anorexia—Mercaptopurine—Crohn's disease	0.000186	0.0025	CcSEcCtD
Ketorolac—Eosinophilia—Mesalazine—Crohn's disease	0.000184	0.00248	CcSEcCtD
Ketorolac—Pneumonia—Azathioprine—Crohn's disease	0.000183	0.00247	CcSEcCtD
Ketorolac—Bronchospasm—Mesalazine—Crohn's disease	0.000183	0.00246	CcSEcCtD
Ketorolac—Pancreatitis—Mesalazine—Crohn's disease	0.000182	0.00245	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000181	0.00243	CcSEcCtD
Ketorolac—Tolmetin—PTGS2—Crohn's disease	0.00018	0.0655	CrCbGaD
Ketorolac—Salsalate—PTGS2—Crohn's disease	0.00018	0.0655	CrCbGaD
Ketorolac—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000178	0.00239	CcSEcCtD
Ketorolac—Pancytopenia—Mesalazine—Crohn's disease	0.000177	0.00238	CcSEcCtD
Ketorolac—Dysuria—Mesalazine—Crohn's disease	0.000174	0.00234	CcSEcCtD
Ketorolac—Arthropathy—Prednisone—Crohn's disease	0.000172	0.00232	CcSEcCtD
Ketorolac—Suprofen—PTGS2—Crohn's disease	0.000172	0.0628	CrCbGaD
Ketorolac—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000172	0.00232	CcSEcCtD
Ketorolac—Pollakiuria—Mesalazine—Crohn's disease	0.000172	0.00231	CcSEcCtD
Ketorolac—Agranulocytosis—Azathioprine—Crohn's disease	0.00017	0.00229	CcSEcCtD
Ketorolac—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00017	0.00229	CcSEcCtD
Ketorolac—Decreased appetite—Mercaptopurine—Crohn's disease	0.000169	0.00228	CcSEcCtD
Ketorolac—Weight increased—Mesalazine—Crohn's disease	0.000169	0.00228	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000168	0.00227	CcSEcCtD
Ketorolac—Pneumonia—Mesalazine—Crohn's disease	0.000167	0.00225	CcSEcCtD
Ketorolac—Ulcer—Prednisone—Crohn's disease	0.000166	0.00223	CcSEcCtD
Ketorolac—Cataract—Prednisone—Crohn's disease	0.000165	0.00222	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000164	0.00221	CcSEcCtD
Ketorolac—Haemoglobin—Azathioprine—Crohn's disease	0.000164	0.00221	CcSEcCtD
Ketorolac—Haemorrhage—Azathioprine—Crohn's disease	0.000163	0.0022	CcSEcCtD
Ketorolac—Renal failure—Mesalazine—Crohn's disease	0.000163	0.00219	CcSEcCtD
Ketorolac—Jaundice—Mesalazine—Crohn's disease	0.000162	0.00218	CcSEcCtD
Ketorolac—Stomatitis—Mesalazine—Crohn's disease	0.000162	0.00218	CcSEcCtD
Ketorolac—Conjunctivitis—Mesalazine—Crohn's disease	0.000161	0.00217	CcSEcCtD
Ketorolac—Vasculitis—Prednisone—Crohn's disease	0.000161	0.00216	CcSEcCtD
Ketorolac—Sweating—Mesalazine—Crohn's disease	0.000159	0.00214	CcSEcCtD
Ketorolac—Haematuria—Mesalazine—Crohn's disease	0.000158	0.00213	CcSEcCtD
Ketorolac—Hiccups—Prednisone—Crohn's disease	0.000157	0.00211	CcSEcCtD
Ketorolac—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000157	0.00211	CcSEcCtD
Ketorolac—Epistaxis—Mesalazine—Crohn's disease	0.000156	0.00211	CcSEcCtD
Ketorolac—Agranulocytosis—Mesalazine—Crohn's disease	0.000155	0.00208	CcSEcCtD
Ketorolac—Erythema multiforme—Azathioprine—Crohn's disease	0.000155	0.00208	CcSEcCtD
Ketorolac—Body temperature increased—Mercaptopurine—Crohn's disease	0.000154	0.00207	CcSEcCtD
Ketorolac—Haemoglobin—Mesalazine—Crohn's disease	0.00015	0.00201	CcSEcCtD
Ketorolac—Rhinitis—Mesalazine—Crohn's disease	0.000149	0.00201	CcSEcCtD
Ketorolac—Fluid retention—Prednisone—Crohn's disease	0.000149	0.002	CcSEcCtD
Ketorolac—Haemorrhage—Mesalazine—Crohn's disease	0.000149	0.002	CcSEcCtD
Ketorolac—Hepatitis—Mesalazine—Crohn's disease	0.000149	0.002	CcSEcCtD
Ketorolac—Immune system disorder—Azathioprine—Crohn's disease	0.000148	0.00199	CcSEcCtD
Ketorolac—Mediastinal disorder—Azathioprine—Crohn's disease	0.000147	0.00198	CcSEcCtD
Ketorolac—Urinary tract disorder—Mesalazine—Crohn's disease	0.000147	0.00198	CcSEcCtD
Ketorolac—Chills—Azathioprine—Crohn's disease	0.000147	0.00197	CcSEcCtD
Ketorolac—Connective tissue disorder—Mesalazine—Crohn's disease	0.000146	0.00197	CcSEcCtD
Ketorolac—Arrhythmia—Azathioprine—Crohn's disease	0.000146	0.00197	CcSEcCtD
Ketorolac—Urethral disorder—Mesalazine—Crohn's disease	0.000146	0.00196	CcSEcCtD
Ketorolac—Alopecia—Azathioprine—Crohn's disease	0.000144	0.00194	CcSEcCtD
Ketorolac—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000144	0.00193	CcSEcCtD
Ketorolac—Oesophagitis—Prednisone—Crohn's disease	0.000143	0.00193	CcSEcCtD
Ketorolac—Ecchymosis—Prednisone—Crohn's disease	0.000142	0.00191	CcSEcCtD
Ketorolac—Erythema multiforme—Mesalazine—Crohn's disease	0.000141	0.00189	CcSEcCtD
Ketorolac—Pulmonary oedema—Prednisone—Crohn's disease	0.00014	0.00188	CcSEcCtD
Ketorolac—Eye disorder—Mesalazine—Crohn's disease	0.000139	0.00187	CcSEcCtD
Ketorolac—Tinnitus—Mesalazine—Crohn's disease	0.000139	0.00187	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000138	0.0444	CbGpPWpGaD
Ketorolac—Cardiac disorder—Mesalazine—Crohn's disease	0.000138	0.00186	CcSEcCtD
Ketorolac—Hyperkinesia—Prednisone—Crohn's disease	0.000137	0.00184	CcSEcCtD
Ketorolac—Sepsis—Prednisone—Crohn's disease	0.000136	0.00183	CcSEcCtD
Ketorolac—Angiopathy—Mesalazine—Crohn's disease	0.000135	0.00182	CcSEcCtD
Ketorolac—Euphoric mood—Prednisone—Crohn's disease	0.000135	0.00181	CcSEcCtD
Ketorolac—Immune system disorder—Mesalazine—Crohn's disease	0.000134	0.00181	CcSEcCtD
Ketorolac—Mediastinal disorder—Mesalazine—Crohn's disease	0.000134	0.00181	CcSEcCtD
Ketorolac—Chills—Mesalazine—Crohn's disease	0.000134	0.0018	CcSEcCtD
Ketorolac—Diarrhoea—Mercaptopurine—Crohn's disease	0.000133	0.0018	CcSEcCtD
Ketorolac—Ill-defined disorder—Azathioprine—Crohn's disease	0.000132	0.00178	CcSEcCtD
Ketorolac—Alopecia—Mesalazine—Crohn's disease	0.000132	0.00177	CcSEcCtD
Ketorolac—Anaemia—Azathioprine—Crohn's disease	0.000132	0.00177	CcSEcCtD
Ketorolac—Mental disorder—Mesalazine—Crohn's disease	0.00013	0.00176	CcSEcCtD
Ketorolac—Erythema—Mesalazine—Crohn's disease	0.00013	0.00174	CcSEcCtD
Ketorolac—Malaise—Azathioprine—Crohn's disease	0.000128	0.00173	CcSEcCtD
Ketorolac—Flatulence—Mesalazine—Crohn's disease	0.000128	0.00172	CcSEcCtD
Ketorolac—Leukopenia—Azathioprine—Crohn's disease	0.000127	0.00171	CcSEcCtD
Ketorolac—Vascular purpura—Prednisone—Crohn's disease	0.000127	0.00171	CcSEcCtD
Ketorolac—Tension—Mesalazine—Crohn's disease	0.000127	0.00171	CcSEcCtD
Ketorolac—Dysgeusia—Mesalazine—Crohn's disease	0.000127	0.00171	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000126	0.0406	CbGpPWpGaD
Ketorolac—Nervousness—Mesalazine—Crohn's disease	0.000126	0.00169	CcSEcCtD
Ketorolac—Cardiac failure congestive—Prednisone—Crohn's disease	0.000126	0.00169	CcSEcCtD
Ketorolac—Back pain—Mesalazine—Crohn's disease	0.000125	0.00169	CcSEcCtD
Ketorolac—Vomiting—Mercaptopurine—Crohn's disease	0.000124	0.00167	CcSEcCtD
Ketorolac—Injury—Prednisone—Crohn's disease	0.000124	0.00167	CcSEcCtD
Ketorolac—Rash—Mercaptopurine—Crohn's disease	0.000123	0.00165	CcSEcCtD
Ketorolac—Dermatitis—Mercaptopurine—Crohn's disease	0.000123	0.00165	CcSEcCtD
Ketorolac—Vision blurred—Mesalazine—Crohn's disease	0.000122	0.00164	CcSEcCtD
Ketorolac—Tremor—Mesalazine—Crohn's disease	0.000121	0.00163	CcSEcCtD
Ketorolac—Increased appetite—Prednisone—Crohn's disease	0.000121	0.00163	CcSEcCtD
Ketorolac—Arthralgia—Azathioprine—Crohn's disease	0.000121	0.00163	CcSEcCtD
Ketorolac—Myalgia—Azathioprine—Crohn's disease	0.000121	0.00163	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00012	0.00162	CcSEcCtD
Ketorolac—Ill-defined disorder—Mesalazine—Crohn's disease	0.00012	0.00162	CcSEcCtD
Ketorolac—Anaemia—Mesalazine—Crohn's disease	0.00012	0.00161	CcSEcCtD
Ketorolac—Discomfort—Azathioprine—Crohn's disease	0.00012	0.00161	CcSEcCtD
Ketorolac—Angioedema—Mesalazine—Crohn's disease	0.000118	0.00159	CcSEcCtD
Ketorolac—Purpura—Prednisone—Crohn's disease	0.000118	0.00159	CcSEcCtD
Ketorolac—Malaise—Mesalazine—Crohn's disease	0.000117	0.00157	CcSEcCtD
Ketorolac—Cardiac failure—Prednisone—Crohn's disease	0.000117	0.00157	CcSEcCtD
Ketorolac—Vertigo—Mesalazine—Crohn's disease	0.000116	0.00157	CcSEcCtD
Ketorolac—Syncope—Mesalazine—Crohn's disease	0.000116	0.00156	CcSEcCtD
Ketorolac—Leukopenia—Mesalazine—Crohn's disease	0.000116	0.00156	CcSEcCtD
Ketorolac—Nausea—Mercaptopurine—Crohn's disease	0.000116	0.00156	CcSEcCtD
Ketorolac—Infection—Azathioprine—Crohn's disease	0.000115	0.00155	CcSEcCtD
Ketorolac—Palpitations—Mesalazine—Crohn's disease	0.000115	0.00154	CcSEcCtD
Ketorolac—Loss of consciousness—Mesalazine—Crohn's disease	0.000114	0.00153	CcSEcCtD
Ketorolac—Osteoarthritis—Prednisone—Crohn's disease	0.000114	0.00153	CcSEcCtD
Ketorolac—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000114	0.00153	CcSEcCtD
Ketorolac—Thrombocytopenia—Azathioprine—Crohn's disease	0.000114	0.00153	CcSEcCtD
Ketorolac—Cough—Mesalazine—Crohn's disease	0.000113	0.00152	CcSEcCtD
Ketorolac—Skin disorder—Azathioprine—Crohn's disease	0.000113	0.00152	CcSEcCtD
Ketorolac—Hypertension—Mesalazine—Crohn's disease	0.000112	0.00151	CcSEcCtD
Ketorolac—Psychotic disorder—Prednisone—Crohn's disease	0.000111	0.0015	CcSEcCtD
Ketorolac—Myalgia—Mesalazine—Crohn's disease	0.00011	0.00149	CcSEcCtD
Ketorolac—Chest pain—Mesalazine—Crohn's disease	0.00011	0.00149	CcSEcCtD
Ketorolac—Arthralgia—Mesalazine—Crohn's disease	0.00011	0.00149	CcSEcCtD
Ketorolac—Anxiety—Mesalazine—Crohn's disease	0.00011	0.00148	CcSEcCtD
Ketorolac—Face oedema—Prednisone—Crohn's disease	0.00011	0.00148	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00011	0.00148	CcSEcCtD
Ketorolac—Discomfort—Mesalazine—Crohn's disease	0.000109	0.00147	CcSEcCtD
Ketorolac—Hypotension—Azathioprine—Crohn's disease	0.000109	0.00146	CcSEcCtD
Ketorolac—Dry mouth—Mesalazine—Crohn's disease	0.000108	0.00145	CcSEcCtD
Ketorolac—Confusional state—Mesalazine—Crohn's disease	0.000107	0.00144	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000106	0.034	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000106	0.00142	CcSEcCtD
Ketorolac—Anaphylactic shock—Mesalazine—Crohn's disease	0.000106	0.00142	CcSEcCtD
Ketorolac—Oedema—Mesalazine—Crohn's disease	0.000106	0.00142	CcSEcCtD
Ketorolac—Infection—Mesalazine—Crohn's disease	0.000105	0.00141	CcSEcCtD
Ketorolac—Shock—Mesalazine—Crohn's disease	0.000104	0.0014	CcSEcCtD
Ketorolac—Nervous system disorder—Mesalazine—Crohn's disease	0.000104	0.0014	CcSEcCtD
Ketorolac—Hypokalaemia—Prednisone—Crohn's disease	0.000104	0.00139	CcSEcCtD
Ketorolac—Thrombocytopenia—Mesalazine—Crohn's disease	0.000104	0.00139	CcSEcCtD
Ketorolac—Tachycardia—Mesalazine—Crohn's disease	0.000103	0.00139	CcSEcCtD
Ketorolac—Skin disorder—Mesalazine—Crohn's disease	0.000103	0.00138	CcSEcCtD
Ketorolac—Hyperhidrosis—Mesalazine—Crohn's disease	0.000102	0.00138	CcSEcCtD
Ketorolac—Anorexia—Mesalazine—Crohn's disease	0.000101	0.00136	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0001	0.00135	CcSEcCtD
Ketorolac—Abdominal distension—Prednisone—Crohn's disease	9.91e-05	0.00133	CcSEcCtD
Ketorolac—Hypotension—Mesalazine—Crohn's disease	9.88e-05	0.00133	CcSEcCtD
Ketorolac—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	9.88e-05	0.0317	CbGpPWpGaD
Ketorolac—Pancreatitis—Prednisone—Crohn's disease	9.65e-05	0.0013	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Mesalazine—Crohn's disease	9.64e-05	0.0013	CcSEcCtD
Ketorolac—Sweating increased—Prednisone—Crohn's disease	9.59e-05	0.00129	CcSEcCtD
Ketorolac—Feeling abnormal—Azathioprine—Crohn's disease	9.57e-05	0.00129	CcSEcCtD
Ketorolac—Insomnia—Mesalazine—Crohn's disease	9.57e-05	0.00129	CcSEcCtD
Ketorolac—Paraesthesia—Mesalazine—Crohn's disease	9.5e-05	0.00128	CcSEcCtD
Ketorolac—Gastrointestinal pain—Azathioprine—Crohn's disease	9.5e-05	0.00128	CcSEcCtD
Ketorolac—Dyspnoea—Mesalazine—Crohn's disease	9.43e-05	0.00127	CcSEcCtD
Ketorolac—Somnolence—Mesalazine—Crohn's disease	9.4e-05	0.00127	CcSEcCtD
Ketorolac—Dyspepsia—Mesalazine—Crohn's disease	9.31e-05	0.00125	CcSEcCtD
Ketorolac—Decreased appetite—Mesalazine—Crohn's disease	9.19e-05	0.00124	CcSEcCtD
Ketorolac—Body temperature increased—Azathioprine—Crohn's disease	9.18e-05	0.00124	CcSEcCtD
Ketorolac—Abdominal pain—Azathioprine—Crohn's disease	9.18e-05	0.00124	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Mesalazine—Crohn's disease	9.13e-05	0.00123	CcSEcCtD
Ketorolac—Fatigue—Mesalazine—Crohn's disease	9.12e-05	0.00123	CcSEcCtD
Ketorolac—Pain—Mesalazine—Crohn's disease	9.05e-05	0.00122	CcSEcCtD
Ketorolac—Constipation—Mesalazine—Crohn's disease	9.05e-05	0.00122	CcSEcCtD
Ketorolac—Weight increased—Prednisone—Crohn's disease	8.96e-05	0.00121	CcSEcCtD
Ketorolac—Hyperglycaemia—Prednisone—Crohn's disease	8.88e-05	0.0012	CcSEcCtD
Ketorolac—Ketoprofen—PTGS2—Crohn's disease	8.76e-05	0.0319	CrCbGaD
Ketorolac—Feeling abnormal—Mesalazine—Crohn's disease	8.72e-05	0.00117	CcSEcCtD
Ketorolac—Acute coronary syndrome—Prednisone—Crohn's disease	8.65e-05	0.00116	CcSEcCtD
Ketorolac—Gastrointestinal pain—Mesalazine—Crohn's disease	8.65e-05	0.00116	CcSEcCtD
Ketorolac—Myocardial infarction—Prednisone—Crohn's disease	8.6e-05	0.00116	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	8.59e-05	0.0276	CbGpPWpGaD
Ketorolac—Hypersensitivity—Azathioprine—Crohn's disease	8.56e-05	0.00115	CcSEcCtD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	8.41e-05	0.027	CbGpPWpGaD
Ketorolac—Urticaria—Mesalazine—Crohn's disease	8.4e-05	0.00113	CcSEcCtD
Ketorolac—Abdominal pain—Mesalazine—Crohn's disease	8.36e-05	0.00113	CcSEcCtD
Ketorolac—Body temperature increased—Mesalazine—Crohn's disease	8.36e-05	0.00113	CcSEcCtD
Ketorolac—Bradycardia—Prednisone—Crohn's disease	8.02e-05	0.00108	CcSEcCtD
Ketorolac—Diarrhoea—Azathioprine—Crohn's disease	7.95e-05	0.00107	CcSEcCtD
Ketorolac—Haemoglobin—Prednisone—Crohn's disease	7.92e-05	0.00107	CcSEcCtD
Ketorolac—Haemorrhage—Prednisone—Crohn's disease	7.88e-05	0.00106	CcSEcCtD
Ketorolac—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	7.84e-05	0.0252	CbGpPWpGaD
Ketorolac—Hallucination—Prednisone—Crohn's disease	7.84e-05	0.00106	CcSEcCtD
Ketorolac—Ketoprofen—ALB—Crohn's disease	7.81e-05	0.0285	CrCbGaD
Ketorolac—Hypersensitivity—Mesalazine—Crohn's disease	7.79e-05	0.00105	CcSEcCtD
Ketorolac—Connective tissue disorder—Prednisone—Crohn's disease	7.74e-05	0.00104	CcSEcCtD
Ketorolac—Dizziness—Azathioprine—Crohn's disease	7.68e-05	0.00103	CcSEcCtD
Ketorolac—Asthenia—Mesalazine—Crohn's disease	7.59e-05	0.00102	CcSEcCtD
Ketorolac—Pruritus—Mesalazine—Crohn's disease	7.48e-05	0.00101	CcSEcCtD
Ketorolac—Vomiting—Azathioprine—Crohn's disease	7.38e-05	0.000994	CcSEcCtD
Ketorolac—Eye disorder—Prednisone—Crohn's disease	7.36e-05	0.000991	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	7.36e-05	0.0236	CbGpPWpGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	7.35e-05	0.0236	CbGpPWpGaD
Ketorolac—Rash—Azathioprine—Crohn's disease	7.32e-05	0.000986	CcSEcCtD
Ketorolac—Dermatitis—Azathioprine—Crohn's disease	7.31e-05	0.000985	CcSEcCtD
Ketorolac—Flushing—Prednisone—Crohn's disease	7.31e-05	0.000984	CcSEcCtD
Ketorolac—Headache—Azathioprine—Crohn's disease	7.27e-05	0.000979	CcSEcCtD
Ketorolac—Diarrhoea—Mesalazine—Crohn's disease	7.24e-05	0.000974	CcSEcCtD
Ketorolac—Angiopathy—Prednisone—Crohn's disease	7.15e-05	0.000962	CcSEcCtD
Ketorolac—Immune system disorder—Prednisone—Crohn's disease	7.11e-05	0.000958	CcSEcCtD
Ketorolac—Arrhythmia—Prednisone—Crohn's disease	7.04e-05	0.000947	CcSEcCtD
Ketorolac—Dizziness—Mesalazine—Crohn's disease	6.99e-05	0.000942	CcSEcCtD
Ketorolac—Alopecia—Prednisone—Crohn's disease	6.96e-05	0.000937	CcSEcCtD
Ketorolac—Mental disorder—Prednisone—Crohn's disease	6.9e-05	0.000929	CcSEcCtD
Ketorolac—Nausea—Azathioprine—Crohn's disease	6.9e-05	0.000929	CcSEcCtD
Ketorolac—Erythema—Prednisone—Crohn's disease	6.86e-05	0.000923	CcSEcCtD
Ketorolac—Malnutrition—Prednisone—Crohn's disease	6.86e-05	0.000923	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	6.82e-05	0.0219	CbGpPWpGaD
Ketorolac—Vomiting—Mesalazine—Crohn's disease	6.73e-05	0.000905	CcSEcCtD
Ketorolac—Rash—Mesalazine—Crohn's disease	6.67e-05	0.000898	CcSEcCtD
Ketorolac—Dermatitis—Mesalazine—Crohn's disease	6.66e-05	0.000897	CcSEcCtD
Ketorolac—Headache—Mesalazine—Crohn's disease	6.63e-05	0.000892	CcSEcCtD
Ketorolac—Vision blurred—Prednisone—Crohn's disease	6.46e-05	0.00087	CcSEcCtD
Ketorolac—Ill-defined disorder—Prednisone—Crohn's disease	6.36e-05	0.000856	CcSEcCtD
Ketorolac—Anaemia—Prednisone—Crohn's disease	6.34e-05	0.000853	CcSEcCtD
Ketorolac—Agitation—Prednisone—Crohn's disease	6.3e-05	0.000848	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	6.28e-05	0.0202	CbGpPWpGaD
Ketorolac—Nausea—Mesalazine—Crohn's disease	6.28e-05	0.000846	CcSEcCtD
Ketorolac—Angioedema—Prednisone—Crohn's disease	6.27e-05	0.000843	CcSEcCtD
Ketorolac—Malaise—Prednisone—Crohn's disease	6.18e-05	0.000832	CcSEcCtD
Ketorolac—Vertigo—Prednisone—Crohn's disease	6.16e-05	0.000829	CcSEcCtD
Ketorolac—Syncope—Prednisone—Crohn's disease	6.15e-05	0.000828	CcSEcCtD
Ketorolac—Loss of consciousness—Prednisone—Crohn's disease	6.03e-05	0.000811	CcSEcCtD
Ketorolac—Convulsion—Prednisone—Crohn's disease	5.94e-05	0.0008	CcSEcCtD
Ketorolac—Hypertension—Prednisone—Crohn's disease	5.92e-05	0.000797	CcSEcCtD
Ketorolac—Arthralgia—Prednisone—Crohn's disease	5.84e-05	0.000786	CcSEcCtD
Ketorolac—Myalgia—Prednisone—Crohn's disease	5.84e-05	0.000786	CcSEcCtD
Ketorolac—Anxiety—Prednisone—Crohn's disease	5.82e-05	0.000783	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	5.8e-05	0.00078	CcSEcCtD
Ketorolac—Discomfort—Prednisone—Crohn's disease	5.77e-05	0.000776	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	5.76e-05	0.0185	CbGpPWpGaD
Ketorolac—Anaphylactic shock—Prednisone—Crohn's disease	5.6e-05	0.000753	CcSEcCtD
Ketorolac—Oedema—Prednisone—Crohn's disease	5.6e-05	0.000753	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	5.59e-05	0.0179	CbGpPWpGaD
Ketorolac—Infection—Prednisone—Crohn's disease	5.56e-05	0.000748	CcSEcCtD
Ketorolac—Shock—Prednisone—Crohn's disease	5.51e-05	0.000741	CcSEcCtD
Ketorolac—Nervous system disorder—Prednisone—Crohn's disease	5.49e-05	0.000739	CcSEcCtD
Ketorolac—Tachycardia—Prednisone—Crohn's disease	5.46e-05	0.000735	CcSEcCtD
Ketorolac—Skin disorder—Prednisone—Crohn's disease	5.44e-05	0.000732	CcSEcCtD
Ketorolac—Hyperhidrosis—Prednisone—Crohn's disease	5.41e-05	0.000728	CcSEcCtD
Ketorolac—Anorexia—Prednisone—Crohn's disease	5.33e-05	0.000718	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	5.15e-05	0.0166	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Prednisone—Crohn's disease	5.1e-05	0.000686	CcSEcCtD
Ketorolac—Insomnia—Prednisone—Crohn's disease	5.06e-05	0.000681	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—Crohn's disease	5.03e-05	0.000676	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	4.99e-05	0.016	CbGpPWpGaD
Ketorolac—Dyspepsia—Prednisone—Crohn's disease	4.93e-05	0.000663	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—Crohn's disease	4.86e-05	0.000655	CcSEcCtD
Ketorolac—Fatigue—Prednisone—Crohn's disease	4.82e-05	0.00065	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	4.79e-05	0.0154	CbGpPWpGaD
Ketorolac—Constipation—Prednisone—Crohn's disease	4.79e-05	0.000644	CcSEcCtD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	4.78e-05	0.0153	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	4.76e-05	0.0153	CbGpPWpGaD
Ketorolac—Feeling abnormal—Prednisone—Crohn's disease	4.61e-05	0.000621	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—Crohn's disease	4.58e-05	0.000616	CcSEcCtD
Ketorolac—Urticaria—Prednisone—Crohn's disease	4.45e-05	0.000598	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	4.44e-05	0.0142	CbGpPWpGaD
Ketorolac—Body temperature increased—Prednisone—Crohn's disease	4.42e-05	0.000596	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—Crohn's disease	4.42e-05	0.000596	CcSEcCtD
Ketorolac—Hypersensitivity—Prednisone—Crohn's disease	4.12e-05	0.000555	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	4.02e-05	0.0129	CbGpPWpGaD
Ketorolac—Asthenia—Prednisone—Crohn's disease	4.02e-05	0.000541	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	4e-05	0.0128	CbGpPWpGaD
Ketorolac—Pruritus—Prednisone—Crohn's disease	3.96e-05	0.000533	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	3.95e-05	0.0127	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	3.89e-05	0.0125	CbGpPWpGaD
Ketorolac—Diarrhoea—Prednisone—Crohn's disease	3.83e-05	0.000515	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	3.8e-05	0.0122	CbGpPWpGaD
Ketorolac—Dizziness—Prednisone—Crohn's disease	3.7e-05	0.000498	CcSEcCtD
Ketorolac—Vomiting—Prednisone—Crohn's disease	3.56e-05	0.000479	CcSEcCtD
Ketorolac—Rash—Prednisone—Crohn's disease	3.53e-05	0.000475	CcSEcCtD
Ketorolac—Dermatitis—Prednisone—Crohn's disease	3.53e-05	0.000475	CcSEcCtD
Ketorolac—Headache—Prednisone—Crohn's disease	3.51e-05	0.000472	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	3.4e-05	0.0109	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	3.33e-05	0.0107	CbGpPWpGaD
Ketorolac—Nausea—Prednisone—Crohn's disease	3.32e-05	0.000447	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	3.14e-05	0.0101	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	3.09e-05	0.00991	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	2.97e-05	0.00955	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.66e-05	0.00853	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	2.52e-05	0.00809	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	2.49e-05	0.008	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.32e-05	0.00744	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.28e-05	0.00731	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	2.2e-05	0.00706	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	2.05e-05	0.00657	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	2e-05	0.00642	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.94e-05	0.00621	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.93e-05	0.0062	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.84e-05	0.00591	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.81e-05	0.0058	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	1.76e-05	0.00566	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.69e-05	0.00543	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.63e-05	0.00523	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	1.57e-05	0.00505	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.54e-05	0.00493	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.53e-05	0.00492	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.52e-05	0.00489	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.52e-05	0.00487	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.51e-05	0.00484	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	1.45e-05	0.00467	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.42e-05	0.00457	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.41e-05	0.00453	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	1.4e-05	0.0045	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	1.4e-05	0.00449	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.25e-05	0.00401	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.2e-05	0.00384	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.14e-05	0.00366	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.12e-05	0.0036	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.11e-05	0.00355	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.03e-05	0.0033	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.01e-05	0.00325	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	9.87e-06	0.00317	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	9.21e-06	0.00296	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	9.06e-06	0.00291	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTMR3—Crohn's disease	8.62e-06	0.00277	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RSPO3—Crohn's disease	8.4e-06	0.0027	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLA2G4F—Crohn's disease	8.05e-06	0.00258	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SEL1L—Crohn's disease	7.96e-06	0.00256	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	7.31e-06	0.00235	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	7.16e-06	0.0023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LTF—Crohn's disease	7.14e-06	0.00229	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTMR3—Crohn's disease	6.84e-06	0.0022	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FADS1—Crohn's disease	6.71e-06	0.00216	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GPX4—Crohn's disease	6.29e-06	0.00202	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GCKR—Crohn's disease	6.07e-06	0.00195	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	5.78e-06	0.00186	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GCKR—Crohn's disease	5.76e-06	0.00185	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FADS1—Crohn's disease	5.33e-06	0.00171	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SLC11A1—Crohn's disease	5.09e-06	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX4—Crohn's disease	4.99e-06	0.0016	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.87e-06	0.00156	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GCKR—Crohn's disease	4.82e-06	0.00155	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HSPA1B—Crohn's disease	4.36e-06	0.0014	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RBX1—Crohn's disease	4.36e-06	0.0014	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.34e-06	0.00139	CbGpPWpGaD
Ketorolac—PTGS2—Disease—UBE2D1—Crohn's disease	3.83e-06	0.00123	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.8e-06	0.00122	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.44e-06	0.00111	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMAD3—Crohn's disease	2.74e-06	0.000879	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—Crohn's disease	1.93e-06	0.000621	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TYK2—Crohn's disease	1.79e-06	0.000573	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAK2—Crohn's disease	1.7e-06	0.000547	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—Crohn's disease	1.69e-06	0.000543	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—Crohn's disease	1.61e-06	0.000518	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—Crohn's disease	1.53e-06	0.000493	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—Crohn's disease	1.25e-06	0.000401	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—Crohn's disease	8.73e-07	0.00028	CbGpPWpGaD
